Your browser doesn't support javascript.
loading
GM-CSF as a systemic adjuvant in a phase II prostate cancer vaccine trial.
Simmons, S J; Tjoa, B A; Rogers, M; Elgamal, A; Kenny, G M; Ragde, H; Troychak, M J; Boynton, A L; Murphy, G P.
Affiliation
  • Simmons SJ; Cancer Research Division, Pacific Northwest Cancer Foundation, Northwest Hospital, Seattle, Washington 98125, USA.
Prostate ; 39(4): 291-7, 1999 Jun 01.
Article in En | MEDLINE | ID: mdl-10344219
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Dendritic Cells / Membrane Glycoproteins / Antigens, CD / Adjuvants, Immunologic / Granulocyte-Macrophage Colony-Stimulating Factor / Cancer Vaccines Type of study: Prognostic_studies Limits: Aged / Humans / Male / Middle aged Language: En Journal: Prostate Year: 1999 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Dendritic Cells / Membrane Glycoproteins / Antigens, CD / Adjuvants, Immunologic / Granulocyte-Macrophage Colony-Stimulating Factor / Cancer Vaccines Type of study: Prognostic_studies Limits: Aged / Humans / Male / Middle aged Language: En Journal: Prostate Year: 1999 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos